Glasgow, UK - REPROCELL has announced the launch of ReproRegistry, a UK-based volunteer registry designed to accelerate skin research and drug discovery. The registry will enable both healthy volunteers and individuals diagnosed with skin conditions such as psoriasis and atopic dermatitis to participate in research studies and clinical trials.
ReproRegistry will play a key role in supporting REPROCELL’s human tissue research programs by connecting to volunteers who wish to help medical research through tissue sample research. These samples enable disease-relevant testing that bridges the gap between preclinical studies and clinical outcomes.
Initially serving the Glasgow area, the registry will expand throughout the UK to create a broader, more diverse participant base. This initiative strengthens REPROCELL’s ability to deliver human-relevant data to clients developing novel dermatology therapies, ultimately reducing the reliance on less predictive models.
With ReproRegistry, REPROCELL reaffirms its commitment to advancing precision medicine by connecting communities with research that has a direct impact on patient care.
Learn more at reproregistry.reprocell.com.
Corporate news by tag